Growth Factor Therapy for Parkinson's Disease: Alternative Delivery Systems

Area of Science:

• Neuroscience
• Biomedical Engineering
• Drug Delivery Systems

Background:

• No cure or preventative treatment exists for neurodegenerative diseases like Parkinson's disease (PD).
• Growth factors offer a promising therapeutic strategy for neuroprotection and neurorestoration in PD by supporting neuron survival.
• Protein-based growth factors face significant delivery challenges, including limited brain penetration and precise targeting of affected areas.

Purpose of the Study:

• To review alternative delivery systems for growth factors in treating neurodegenerative conditions.
• To highlight the potential of ex vivo gene therapy and biomaterial-aided delivery systems.
• To provide perspectives on the clinical development and translation of these novel delivery methods.

Main Methods:

• Review of existing literature on growth factor delivery systems for neurodegenerative diseases.
• Focus on ex vivo gene therapy approaches.
• Examination of biomaterial-aided protein and gene delivery strategies.

Main Results:

• Direct infusion and in vivo gene therapy are current clinical approaches for growth factor delivery in PD.
• Alternative methods like ex vivo gene therapy and biomaterial-aided delivery show significant potential.
• These alternative systems aim to overcome the limitations of traditional growth factor administration.

Conclusions:

• Novel delivery systems are crucial for advancing neurotrophin-based therapies for neurodegenerative diseases.
• Ex vivo gene therapy and biomaterial-aided delivery represent promising avenues for future clinical translation.
• Further research and development are needed to optimize these systems for effective neuroprotection and neurorestoration.